Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a secreted protein that plays an important role in regulating plasma cholesterol and cardiovascular disease risk. PCSK9 secretion uniquely depends on the cytoplasmic COPII protein SEC24A, suggesting the presence of a transmembrane ER cargo receptor mediating this interaction. Here, we report a novel approach that combines proximity-dependent biotinylation and proteomics together with genome-scale CRISPR screening to identify proteins that facilitate the efficient secretion of PCSK9 heterologously expressed in HEK293T cells. We first identified 35 candidate proteins that were labeled by BirA* fusions to PCSK9 and either COPII component SAR1A or SAR1B.
INTRODUCTION
PCSK9 is a proprotein convertase that acts as a negative regulator of the LDL receptor 1 .
PCSK9 is synthesized primarily in hepatocytes and secreted into the bloodstream. Circulating PCSK9 binds to the LDL receptor and diverts it to lysosomes for degradation, thereby leading to decreased LDL receptor abundance at the hepatocyte cell surface, decreased LDL clearance, and hypercholesterolemia. PCSK9 was originally implicated in cardiovascular disease when human genetic studies identified gain-of-function PCSK9 mutations as a cause of familial hypercholesterolemia 2 . Subsequently, loss-of-function PCSK9 variants were associated with decreased plasma cholesterol and lowered lifetime incidence of cardiovascular disease 3, 4 .
Therapeutic inhibitors of PCSK9 have been recently developed that exhibit potent lipid-lowering effects and are associated with a reduction in cardiovascular events 5, 6 .
A critical early sorting step for secreted proteins is their incorporation into membrane-bound vesicles that transport cargoes from the ER to the Golgi apparatus 7 . The formation of these vesicles is driven by coat protein complex II (COPII), which includes the SAR1 GTPase, heterodimers of SEC23/SEC24, and heterotetramers of SEC13/SEC31. Secreted cargoes are incorporated into COPII vesicles by two mechanisms. "Cargo capture" refers to concentrative, receptor-mediated, active sorting of selected cargoes, in contrast to "bulk flow", by which cargoes enter COPII vesicles through passive diffusion. These mechanisms are not mutually exclusive, as cargoes may exhibit basal rates of secretion that are enhanced by receptormediated recruitment. It remains unclear to what extent protein recruitment into the secretory pathway is driven by selective cargo capture versus passive bulk flow 8 .
In yeast, the active sorting of secreted cargoes into COPII-coated vesicles is driven primarily by Sec24, which is encoded by a single, essential gene. In mammals, multiple paralogs of SEC24 exist, potentially accommodating a more diverse and regulated repertoire of cargoes. Genetic deficiency in the mouse for one of these paralogs, SEC24A, results in hypocholesterolemia due to reduced secretion of PCSK9 from hepatocytes 9 . This finding suggested an active receptormediated mechanism for PCSK9 recruitment into COPII vesicles. A direct physical interaction between SEC24A and PCSK9, however, is implausible since SEC24A localizes to the cytoplasmic side of the ER membrane and PCSK9 to the luminal side, with neither possessing a transmembrane domain. This topology instead implies the presence of an ER cargo receptor, a transmembrane protein that could serve as an intermediary between the COPII coat and luminal PCSK9.
Although COPII-dependent ER cargo receptors were first identified in yeast nearly two decades ago, few examples of similar cargo receptor interactions have been reported for mammalian secreted proteins 8 . Previous investigation of the ER cargo receptor LMAN1 demonstrated no specificity for SEC24A over other SEC24 paralogs, making this unlikely to serve as a PCSK9 cargo receptor 10 . Earlier analyses of PCSK9-interacting proteins [11] [12] [13] did not identify a clear receptor mediating PCSK9 secretion. Here, we developed a novel strategy for ER cargo receptor identification that combines proximity-dependent biotinylation with CRISPR-mediated functional genomic screening. This approach led to the identification of the ER cargo receptor SURF4 as a primary mediator of PCSK9 secretion in HEK293T cells.
RESULTS

Identification of candidate PCSK9 cargo receptors by proximity-dependent biotinylation.
To identify PCSK9-interacting proteins, we first engineered cells expressing a fusion of PCSK9 and a mutant biotin ligase, E. coli BirA*(R118G), that catalyzes proximity-dependent biotinylation of primary amines on neighboring proteins within an estimated ~10 nm radius 14, 15 , effectively converting transient interactions into covalent modification ( Figure 1A ). The high affinity of the biotin-streptavidin interaction in turn allows for stringent detergent and high salt conditions during purification. Quantitative mass spectrometry of streptavidin-purified interacting proteins from cells expressing PCSK9-BirA* identified 162 prey proteins that were specifically labeled (Bayesian FDR ≤1%) by PCSK9-BirA* relative to control bait proteins (Supplemental Table 1 ).
To refine the candidate list of PCSK9-interacting proteins, we next analyzed cells expressing a fusion of BirA* with a control secreted protein, alpha-1 antitrypsin (A1AT). The interactome of A1AT showed substantial overlap with that of PCSK9 (108/162 proteins, Figure 1C ). The A1AT cargo receptor LMAN1 was similarly labeled by both PCSK9-BirA* and A1AT-BirA*, suggesting that the restricted environment of the COPII vesicle may lead to nonspecific labeling of adjacent cargo receptors. We next compared the interactome of PCSK9 to that of SAR1A and SAR1B ( Figure 1D ), COPII proteins that localize to the cytoplasmic surface of budding COPII vesicles, identifying a total of 35 candidate ER cargo receptors interacting with both PCSK9 and either SAR1A or SAR1B ( Figure 1E -F, Supplemental Table 1 ). The majority of these candidates were annotated as integral membrane proteins (32/35, p = 3x10 -16 ) with localization in the ER (24/35, p = 1.6x10 -18 ), as would be expected for an ER cargo receptor (Supplemental Table 1 ).
A genome-scale CRISPR screen identifies SURF4 as a putative ER cargo receptor for PCSK9.
We next developed a functional screen to identify genes involved in PCSK9 secretion ( Figure   2A ). We reasoned that mutants with reduced PCSK9 exit from the ER would accumulate intracellular PCSK9, and that fusion of PCSK9 to eGFP would allow for a cell-autonomous, scalable, and selectable readout of PCSK9 accumulation. We generated clonal HEK293T cell lines stably co-expressing both a PCSK9-eGFP fusion and, as an internal control, alpha-1 antitrypsin fused with mCherry. Immunoblotting verified the efficient secretion of both fusion proteins from clonal reporter cell lines (Supplemental Figure 1 ).
Treatment of these reporter cells with brefeldin A, a pharmacologic inhibitor of COPII function,
resulted in intracellular accumulation of both PCSK9-eGFP and A1AT-mCherry ( Figure 2B ), consistent with ER exit and secretion of both fusion proteins through the COPII pathway.
CRISPR-mediated inhibition of the ER cargo receptor for A1AT, LMAN1 16, 17 , resulted in intracellular accumulation of A1AT-mCherry with no effect on PCSK9-eGFP ( Figure 2B ). To screen for specific modifiers of PCSK9 secretion, we next sought to identify single guide RNAs Figure 2C ). The enrichment of SURF4-targeting sgRNA in eGFP-high cells was consistent across each of 4 biologic replicates and, after adjustment for multiple hypothesis testing, statistically significant for 5 of the 6 SURF4-targeting sgRNAs in the library (p <10 -13 -10 -36 , Figure 3A ). Gene-level analysis confirmed the strongest enrichment for SURF4-targeting sgRNA ( Figure 2D ). SURF4 is a homologue of yeast Erv29, an ER cargo receptor that mediates the secretion of glycosylated pro-alpha-factor 19 . Comparison of candidate PCSK9 cargo receptors identified by either CRISPR functional screening (Supplemental Table 3 ) or proximitydependent biotinylation ( Figure 1F ) demonstrated that SURF4 was the only candidate identified by both approaches.
SURF4 deletion causes intracellular accumulation of PCSK9-eGFP in HEK293T cells.
To validate the functional interaction of SURF4 with PCSK9-eGFP, we generated plasmids encoding Cas9 and 6 independent SURF4-targeting sgRNAs (3 from the original screen and 3 additional unique sgRNAs). Reporter cells were transiently transfected with each of these 6 SURF4-targeting constructs and analyzed by FACS, with all 6 sgRNAs resulting in accumulation of intracellular PCSK9-eGFP fluorescence with no effect on intracellular A1AT-mCherry fluorescence ( Figure 3B -C). Similarly, 6 clonal cell lines carrying sequence-verified indels in either SURF4 exon 2 or exon 5 (Supplemental Figure 3 ) all exhibited specific PCSK9-eGFP accumulation with no effect on A1AT-mCherry ( Figure 3D ). This phenotype was rescued by stable expression of wild-type SURF4 cDNA ( Figure 3E ). The intracellular accumulation of PCSK9 upon SURF4 disruption was confirmed in an independently-derived HEK293T cell line carrying an inducible PCSK9-eGFP allele. Accumulation of PCSK9-eGFP in SURF4 mutant cells relative to wild-type cells was detectable within 4 hr of induction ( Figure 3F ).
To exclude interaction of SURF4 with the GFP portion of the fusion rather than PCSK9 itself, we also examined SURF4-dependence for the secretion of untagged PCSK9. Stable cell lines were generated by Flp/FRT-mediated knock-in of PCSK9 coding sequence into a tetracycline-inducible locus of HEK293T cells that were either wild-type or SURF4-deficient, the latter with or without stable integration of a wild-type SURF4 cDNA expression construct. Consistent with the reduced secretion observed above for the PCSK9-eGFP fusion, untagged PCSK9 also exhibited intracellular accumulation in the absence of SURF4 that was rescued by expression of a SURF4 transgene ( Figure 5B -C). Deletion of SURF4 in these cells did not induce activation of ER stress markers (Supplemental Figure 4 ).
To identify other potential cellular components also required for efficient PCSK9 secretion, we next examined the 21 genes in addition to SURF4 which exhibited potentially significant enrichment scores (FDR≤10%) in the whole genome CRISPR screen. PCSK9-eGFP-2A-A1AT-mCherry reporter cells were transduced with individual lentiviral CRISPR constructs targeting each of these genes and analyzed by FACS. None of the sgRNA targeting these additional genes were found to result in a significant effect specifically on PCSK9-eGFP fluorescence (Supplemental Figure 5 ). Thus, within the statistical power of our screen, SURF4 emerges as the single gene out of the ~19,000 human genes targeted by the GeCKOv2 library 18 whose inactivation results in specific intracellular retention of PCSK9 in HEK293T cells.
SURF4 localizes to the early secretory pathway where it physically interacts with PCSK9.
HEK293T cells were engineered to stably express SURF4 with an N-terminal FLAG epitope tag. FLAG-tagged SURF4 demonstrated similar rescue of PCSK9-eGFP fluorescence in SURF4deficient cells compared to native, untagged SURF4 ( Figure 3E ), demonstrating that this tag does not interfere with SURF4 function. Consistent with previous reports 20, 21 and compatible with a role for SURF4 as an ER cargo receptor, immunofluorescence of FLAG-SURF4 demonstrated colocalization with a marker of the ER and, to a lesser extent, the ERGIC compartment ( Figure 4A-B ). Co-immunoprecipitation of cell lysates prepared in the presence of the chemical crosslinker dithiobis(succinimidyl propionate) demonstrated a physical interaction between FLAG-tagged SURF4 and GFP-tagged PCSK9 ( Figure 4D ).
Loss of SURF4 results in decreased PCSK9 secretion and ER accumulation of PCSK9.
Fluorescence assays on both extracellular conditioned media and intracellular lysates prepared from both wild-type and SURF4-deficient cells demonstrated a significantly decreased ratio of extracellular to intracellular PCSK9-eGFP fluorescence ( Figure 5A ), consistent with a defect in extracellular secretion. We also tested the dependence of untagged PCSK9 secretion on 
DISCUSSION
It is estimated that ~3000 human proteins are extracellularly secreted through the COPII pathway 23 , though few ER cargo receptors for these proteins have been identified and the proportion of secreted proteins that depend upon cargo receptor interactions is unknown 8 . Our findings suggest that SURF4 actively recruits PCSK9 into COPII vesicles, providing additional support for the cargo capture model of protein secretion. SURF4-deleted cells exhibit only a partial defect in PCSK9 secretion and whether the residual SURF4-independent secretion is due to bulk flow, or interactions with alternative ER cargo receptors, remains unknown.
To potentially circumvent the expected transient and/or low affinity nature of interactions between cargoes and their receptors, we applied purification by BirA*-mediated proximitydependent biotinylation, which converts transient protein-protein interactions into permanent modifications 14 . Although this approach led to the detection of SURF4 interactions with PCSK9, SAR1A, and SAR1B, SURF4 was similarly marked by A1AT. Likewise, the A1AT cargo receptor LMAN1 was marked by both A1AT and PCSK9. These data suggest that BirA*-mediated proximity-dependent biotinylation may efficiently label ER cargo receptors, but lack the spatiotemporal resolution to distinguish incorporation within the same COPII vesicle from specific cargo -cargo receptor interactions. CRISPR/Cas9-mediated gene editing has emerged as an efficient, programmable, and highthroughput tool for forward genetic screening in mammalian cells 24 . Our discovery of the PCSK9-SURF4 interaction demonstrates the feasibility of identifying ER cargo receptors by functional genomic screening and suggests that pooled CRISPR screening may prove to be a generalizable strategy applicable to the thousands of other secreted proteins for which a cargo receptor has not yet been identified. A limitation of our approach is its reliance on an immortalized cell line with the potential for accumulated somatic genetic and epigenetic changes, as well as restriction to a single cell-type gene expression program. Though LMAN1 cargoes appear to retain their cargo receptor-dependence for secretion in a variety of distantly related cell types 16, 25, 26 , the same many not apply to SURF4. Of note, SEC24A and/or SEC24B were previously shown to be required for efficient PCSK9 secretion in mice 9 . Though these genes were not identified in the current screen, this observation could be explained by the 5-10 fold greater expression of SEC24A than SEC24B in mouse liver, in contrast to the similar expression of both paralogs in HEK293T cells 27 .
In addition to a cargo receptor facilitating ER exit, our screening strategy should also survey other segments of the secretory pathway. Though sortilin has previously been implicated in post-Golgi transport of PCSK9 28 , sortilin dependence was not confirmed in a subsequent study 29 and also was not detected in the current screen. However, our data do not exclude a broader role for sortilin that also affected A1AT secretion, consistent with its contribution to the secretion of other proteins, including gamma-interferon 30 and ApoB-100 31 .
The yeast homologue of SURF4, Erv29p, was originally identified by proteomic analysis of purified COPII vesicles 32 . Erv29p promotes the secretion and concentrative sorting of the yeast mating factor gpαf into COPII vesicles through interaction with a hydrophobic I-L-V signal in gpαf 19, 33, 34 . In HeLa cells, SURF4 has been shown to cycle in the early secretory pathway and to interact with LMAN1 and members of the p24 family. RNAi-mediated knockdown of SURF4 alone resulted in no overt phenotype, though when combined with knockdown of LMAN1 caused morphologic changes to the ERGIC and Golgi compartments 20 . SURF4 has also been shown to interact with STIM1 and modulate store-operated calcium entry, though the mechanism underlying this observation is unclear 35 . Our screen did not identify significant enrichment of sgRNAs targeting p24 proteins, LMAN1, or STIM1, suggesting that these interactions are not required for efficient PCSK9 secretion in HEK293T cells.
Taken together with the marked reductions in plasma cholesterol associated with genetic or therapy-induced reductions in plasma PCSK9 [3] [4] [5] [6] , our findings raise the possibility that SURF4 could represent an additional novel therapeutic target for the treatment of hypercholesterolemia.
However, SURF4 has not been identified in genome-wide association studies for human lipid phenotypes 36, 37 , suggesting that partial reduction of SURF4 expression does not limit PCSK9 secretion, consistent with the normal PCSK9 secretion and cholesterol profiles of Sec24A +/mice 9 and the normal levels of LMAN1 cargoes (coagulation factors V, VIII, and A1AT) in LMAN1 +/mice 17 . Though a loss-of-function variant (p.Gln185Ter) is present in ~1:500 individuals 38 , no human diseases have been associated with SURF4 deficiency and no mouse models for Surf4 deletion have been reported 39 . Erv29, the SURF4 homolog in yeast, is required for gpαf secretion and the C. elegans homolog (SFT-4) facilitates the secretion of yolk lipoproteins 21 , with the latter report also demonstrating a role for SURF4 in apolipoprotein B secretion in HepG2 cells. Thus, it seems highly likely that additional SURF4 cargoes remain to be identified. Harvested media was centrifuged at 1000g for 10 min, pooled and filtered through a 0.45 μm filter, aliquoted, snap-frozen with liquid nitrogen and stored at -80°C until the time of use. nucleotide barcode and downstream 20 nucleotide sgRNA sequence, which was then mapped to the library reference database with no mismatches tolerated. Enrichment was assessed using DESeq2 for individual sgRNA sequences 44 and MAGeCK for gene-level computations 45 . 
MATERIALS AND METHODS
Cells and reagents
Whole genome CRISPR screen
PCSK9 secretion assays
Endoglycosidase H assays
To test for the N-glycosylation state of PCSK9, approximately 100 μg of RIPA lysate was incubated with denaturation buffer (NEB, Ipswich MA) for 10 minutes at 95°C, then split in half and incubated with or without 0.5 μL of PNGase (NEB) or EndoH (NEB) for 1 hr at 37°C.
Laemmli sample buffer 47 was added, samples boiled for 5 min, resolved on a 10% Tris-HCl polyacrylamide gel, and analyzed by immunoblotting as above. 
Microscopy
BioID and mass spectrometry
BioID and mass spectrometry analysis was performed essentially as described 49 . Briefly, stable HEK293 Flp-In T-REx cells were grown on 15 cm plates to approximately 75% confluence. Bait expression and proximity labeling were induced by the addition of tetracycline (1 μg/mL) and biotin (50 μM) and proceeded for 24 hours. Cells were collected in PBS and biotinylated proteins purified by streptavidin-agarose affinity purification. Proteins were digested on-bead with sequencing-grade trypsin in 50 mM ammonium bicarbonate pH 8.5. Peptides were acidified by the addition of formic acid (2% (v/v) final) and dried by vacuum centrifugation. Dried peptides were suspended in 5% (v/v) formic acid and analysed on a TripleTOF 6600 mass spectrometer (SCIEX) in-line with a nanoflow electrospray ion source and nano-HPLC system. Raw data were searched and analyzed within ProHits LIMS 50 and peptides matched to genes to determine prey spectral counts 51 . High confidence proximity interactions (BFDR≤1%) were determined through SAINT analysis 52 implemented within ProHits. Bait samples (biological duplicates) were compared against 14 independent negative control samples (2 BirA*-FLAG-GFP only, 6 BirA*-FLAG only, and 6 3xFLAG only expressing cell lines) which were "compressed" to 6 virtual controls to increase the stringency in scoring 53 . Data has been deposited as a complete submission to the MassIVE repository (https://massive.ucsd.edu/ProteoSAFe/static/massive.jsp) and assigned the accession number MSV000082222. The ProteomeXchange accession is PXD009368.
Mass spectrometry data analysis
All raw (WIFF and WIFF.SCAN) files were saved in our local interaction proteomics LIMS, ProHits 50 . mzXML files were generated from raw files using the ProteoWizard (v3.0.4468) and SCIEX converter (v1.3 beta) converters, implemented within ProHits. The searched database contained the human complement of the RefSeq protein database (version 57) complemented with SV40 large T-antigen sequence, protein tags, and common contaminants (72,226 sequences searched including decoy sequences). mzXML files were searched by Mascot (v2.3.02) and Comet (v2016.01 rev. 2) with up to two missed trypsin cleavage sites allowed and methionine oxidation and asparagine/glutamine deamidation set as variable modifications. The fragment mass tolerance was 0.15 Da and the mass window for the precursor was ±30 ppm with charges of 2+ to 4+ (both monoisotopic mass). Search engine results were analyzed using the Trans-Proteomic Pipeline (TPP v4.6 OCCUPY rev 3 check) 54 via iProphet 55 . Peptides with PeptideProphet scores ≥ 0.85 were mapped back to genes (gene IDs were from RefSeq). If peptides were shared between multiple genes, spectral counts were assigned exclusively to those genes with unique peptide assignments proportionally to the evidence for that assignment. If peptides matched only to genes without unique peptide assignments, spectral counts were divided equally between those genes 51 . SAINTexpress (v3.6.1) 52 was used to calculate the probability that identified proteins were significantly enriched above background contaminants using spectral counting (semi-supervised clustering) through comparing bait runs to negative control runs.
Immunoprecipitation
Cells were harvested and resuspended at a density of ~5x10 6 cells/mL in PBS supplemented with 2 mM CaCl2 and 2 mM dithiobis(succinimidyl propionate) (Pierce, Waltham MA), rotated end-over-end at 4⁰C, quenched with the addition of Tris-HCl (pH 7.5) to a final concentration of 25 mM, pelleted, and resuspended in lysis buffer (50 mM Tris-HCl, 150 mM NaCl, 2 mM CaCl2, and 1.0% Triton X-100, supplemented with protease inhibitors (Roche), pH 7.5). Lysates were prepared as described above. Immunoprecipitation from lysates was performed with M2-FLAG affinity gel (Sigma) or GFP-trap magnetic beads (Chromo-Tek, Hauppage NY). To reduce nonspecific binding, M2-FLAG affinity gel was pre-blocked with 1 hr incubation in High Salt Wash Buffer (50 mM Tris-HCl, 500 mM NaCl, 2 mM CaCl2, pH 7.5) supplemented with 5% BSA.
Pulldowns were performed with 500 µL of lysate with end-over-end rotation at 4⁰C overnight. A total of 5 washes were performed with Wash Buffer (50 mM Tris-HCl, 500 mM NaCl, 2 mM CaCl2, pH 7.5) for GFP-trap beads or High Salt Wash Buffer for M2-FLAG affinity gel. Protein elution was performed by incubating beads at room temperature for 15 min with 2X Laemmli sample buffer supplemented with β-mercaptoethanol.
Screen validation
All genes identified by MaGECK with a FDR<10% were selected for follow up validation. The top-ranking sgRNA for each gene was individually cloned into BsmBI sites of pLentiCRISPRv2.
Individual lentiviral stocks were prepared and used to transduce fluorescent reporter cells at an MOI <0.5, followed by puromycin selection, and passaging for 2 weeks prior to FACS analysis.
The mean fluorescence intensity of a total of 20,000 gated events was recorded for each construct and compared to the mean intensity of 3 nontargeting sgRNA constructs. A total of 3 biologic replicates was performed.
Statistical Analysis
The statistical significance of differences in quantitative data between control and experimental groups was calculated using the student's t-test. CRISPR screen and mass spectrometry data analysis was performed as described above. Supplemental Table 3 . CRISPR screen gene-level analysis. Enrichment for each sgRNA targeting the same gene was combined to generate a gene-level enrichment score using MAGeCK 45 , which is displayed in the column corresponding to the number of unique sgRNA targeting that same that demonstrated enrichment (p<0.05) by analysis with DESeq2 (Supplemental Table 2 ).
Supplemental Table 4 . Oligonucleotide sequences. Primers used for CRISPR/Cas9 targeting and genotyping are displayed. 
